Association between human leukocyte antigen class II alleles and human papillomavirus-mediated cervical cancer in Indian women

Human Immunology

Volumn 70, Issue 4, 2009, Pages 222-229

  Kohaar, Indu ^a   Hussain, Showket ^a   Thakur, Nisha ^a   Tiwari, Pratibha ^a   Nasare, Vilas ^a   Batra, Swaraj ^b   Singh, Veena ^a   Bhambani, Suresh ^a   Das, Bhudev C ^a   Sarkar, Debi P ^c   Bharadwaj, Mausumi ^a  

^a Institute of Cytology and Preventive Oncology ICMR   (India)

^b LNJP Hospital   (India)

^c UNIVERSITY OF DELHI   (India)

Author keywords

Cervical cancer; Human leukocyte antigen (HLA); Human papillomavirus; Polymorphism

Indexed keywords

HLA A2 ANTIGEN;

ADULT; AGED; ARTICLE; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; GENE FREQUENCY; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HUMAN; INDIAN; INFECTION RISK; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SCREENING; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; WART VIRUS;

ADULT; AGED; ALLELES; CASE-CONTROL STUDIES; CERVICAL INTRAEPITHELIAL NEOPLASIA; CHI-SQUARE DISTRIBUTION; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; INDIA; LINKAGE DISEQUILIBRIUM; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 62949172291     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2009.01.003     Document Type: Article

References (60)

1. Parkin D.M., and Bray F. The burden of HPV-related cancers. Vaccine 24 (2006) S11-S25
2. Nanda Kumar A., and Settee M.T.T. Incidence and distribution of cancer: 1997-98: a two year of the population based cancer registry, National Cancer Registry Programme (2001), Indian Council of Medical Research, New Delhi
3. Hausen H.Z. Papillomavirus infections: a major cause of human cancers. Biochem Biophys Acta 1288 (1996) 55-78
4. Das B.C., Hussain S., Nasare V., and Bharadwaj M. Prospects and prejudices of human papillomavirus vaccines in India. Vaccine 26 (2008) 2669-2679
5. Kohaar I., Thakur N., Salhan S., Batra S., Singh V., Sharma A., et al. TNFα-308G/A polymorphism as a risk factor for HPV associated cervical cancer in Indian population. Cell Oncol 29 (2007) 249-256
6. Cheng W.F., Lee C.N., Su Y.N., Chang M.C., Hsiao W.C., Chen C.A., et al. Induction of human papillomavirus type 16-specific immunologic responses in normal and human papillomavirus-infected populations. Immunology 115 (2005) 136-149
7. Bateman A.C., and Howell W.M. Human leukocyte antigens and cancer: is it in our genes?. J Pathol 188 (1999) 231-236
8. Hilders C.G., Houbiers J.G., Krul E.J., and Fleuren G.J. The expression of histocompatibility-related leukocyte antigens in the pathway to cervical carcinoma. Am J Clin Pathol 101 (1994) 5-12
9. Klein J., and Sato A. The HLA system. First of two parts. N Engl J Med 343 (2000) 702-709
10. Tang J., Costello C., Keet I.P., Rivers C., Leblanc S., Karita E., et al. HLA class I homozygosity accelerates disease progression in human immunodeficiency virus type 1 infection. AIDS Res Hum Retroviruses 15 (1999) 317-324
11. Thursz M.R., Thomas H.C., Greenwood B.M., and Hill A.V. Heterozygote advantage for HLA class-II type in hepatitis B virus infection. Nat Genet 17 (1997) 11-12
12. Hill A.V. The immunogenetics of human infectious diseases. Annu Rev Immunol 16 (1998) 593-617
13. Asti M., Martinetti M., Zavaglia C., Cuccia M.C., Gusberti L., Tinelli C., et al. Human leukocyte antigen class II and III alleles and severity of hepatitis C virus-related chronic liver disease. Hepatology 29 (1999) 1272-1279
14. Jeffery K.J., Siddiqui A.A., Bunce M., Lloyd A.L., Vine A.M., Witkover A.D., et al. The influence of HLA class I alleles and heterozygosity on the outcome of human T cell lymphotropic virus type I infection. J Immunol 165 (2000) 7278-7284
15. Beskow A.H., Moberg M., and Gyllensten U.B. HLA class II allele control of HPV load in carcinoma in situ of the cervix uteri. Int J Cancer 117 (2005) 510-514
16. Hildesheim A., and Wang S. Host and viral genetics and risk of cervical cancer: a review. Virus Res 89 (2002) 229-240
17. Sambrook J., Fritsh E.F., and Maniatis T. Molecular cloning: a laboratory manual (1989), Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY 9.16-9.19
18. Manos M.M., Ting Y., Wright D.K., Lewis A.J., Broker T.R., and Wolinski S.M. Use of polymerase chain reaction amplification for the detection of genital human papillomaviruses. Cancer Cells 7 (1989) 209-214
19. Saiki R.K., Gelfand D.H., Stoffel S., Scharf S.J., Higuchi R., Horn G.T., et al. Primer-directed amplification of DNA with a thermostable DNA Polymerase. Science 239 (1988) 487-491
20. Rani R., Fernandez-Vina M.A., and Stastry P. Association between HLA class II alleles in a north Indian population. Tissue Antigens 52 (1998) 37-43
21. Das B.C., Sharma J.K., Gopalkrishna V., Das D.K., Singh V., Gissmann L., et al. A high frequency of human papillomavirus DNA sequences in cervical carcinomas of Indian women as revealed by Southern blot hybridization and polymerase chain reaction. J Med Virol 36 (1992) 239-245
22. Bhattacharya P., and Sengupta S. HLA DQB1*03 genotypes and susceptibility to cervical cancer in Indian women. Int J Hum Genet 5 (2005) 19-25
23. Sanjeevi C.B., Hjelmstrom P., Hallmans G., Wiklund F., Lenner P., Angstrom T., et al. Different HLA-DR-DQ haplotypes are associated with cervical intraepithelial neoplasia among human papillomavirus type-16 seropositive and seronegative Swedish women. Int J Cancer 68 (1996) 409-414
24. Krul E.J., Schipper R.F., Schreuder G.M., Fleuren G.J., Kenter G.G., and Melief C.J. HLA and susceptibility to cervical neoplasia. Hum Immunol 60 (1999) 337-342
25. Yang Y.C., Chang T.Y., Lee Y.J., Su T.H., Dang C.W., Wu C.C., et al. HLA-DRB1 alleles and cervical squamous cell carcinoma: experimental study and meta-analysis. Hum Immunol 67 (2006) 331-340
26. Schiff M.A., Apple R.J., Lin P., Nelson J.L., Wheeler C.M., and Becker T.M. HLA alleles and risk of cervical intraepithelial neoplasia among southwestern American Indian women. Hum Immunol 66 (2005) 1050-1056
27. Beskow A.H., Josefsson A.M., and Gyllensten U.B. HLA class II alleles associated with infection by HPV16 in cervical cancer in situ. Int J Cancer 93 (2001) 817-822
28. Apple R.J., Erlich H.A., Klitz W., Manos M.M., Becker T.M., and Wheeler C.M. HLA DR-DQ associations with cervical carcinoma show papillomavirus-type specificity. Nature Genet 6 (1994) 157-162
29. Helland A., Olsen A.O., Gjoen K., Akselsen H.E., Sauer T., Magnus P., et al. An increased risk of cervical intra-epithelial neoplasia grade II-III among human papillomavirus positive patients with the HLA-DQA1*0102-DQB1*0602 haplotype: a population-based case-control study of Norwegian women. Int J Cancer 76 (1998) 19-24
30. Maciag P.C., Schlecht N.F., Souza P.S., Franco E.L., Villa L.L., and Petzl-Erler M.L. Major histocompatibility complex class II polymorphisms and risk of cervical cancer and human papillomavirus infection in Brazilian women. Cancer Epidemiol Biomarkers Prev 9 (2000) 1183-1191
31. Hildesheim A., Schiffman M., Scott D.R., Marti D., Kissner T., Sherman M.E., et al. Human leukocyte antigen class I/II alleles and development of human papillomavirus-related cervical neoplasia: results from a case-control study conducted in the United States. Cancer Epidemiol Biomed Prev 7 (1998) 1035-1041
32. Ades S., Koushik A., Duarte-Franco E., Mansour N., Arseneau J., Provencher D., et al. Selected class I and class II HLA alleles and haplotypes and risk of high-grade cervical intraepithelial neoplasia. Int J Cancer 122 (2008) 2820-2826
33. Wu Y., Liu B., Lin W., Xu Y., Li L., Zhang Y., et al. HPV16 E6 variants and HLA class II polymorphism among Chinese women with cervical cancer. J Med Virol 79 (2007) 439-446
34. Madeleine M.M., Brumback B., Cushing-Haugen K.L., Schwartz S.M., Daling J.R., Smith A.G., et al. Human leukocyte antigen class II and cervical cancer risk: a population-based study. J Infect Dis 186 (2002) 1565-1574
35. Bontkes H.J., van Duin M., de Gruijl T.D., Duggan-Keen M.F., Walboomers J.M., Stukart M.J., et al. HPV 16 infection and progression of cervical intra-epithelial neoplasia: analysis of HLA polymorphism and HPV 16 E6 sequence variants. Int J Cancer 78 (1998) 166-171
36. Wang S.S., Wheeler C.M., Hildesheim A., Schiffman M., Herrero R., Bratti M.C., et al. Human leukocyte antigen class I and II alleles and risk of cervical neoplasia: results from a population-based study in Costa Rica. J Infect Dis 184 (2001) 1310-1314
37. Cuzick J., Terry G., Ho L., Monaghan J., Lopes A., Clarkson P., et al. Association between high risk HPV types, HLA DRB1* and DQB1* alleles and cervical cancer in British women. Br J Cancer 82 (2000) 1348-1352
38. Apple R.J., Becker T.M., Wheeler C.M., and Erlich H.A. Comparison of human leukocyte antigen DR-DQ disease associations found with cervical dysplasia and invasive cervical carcinoma. J Natl Cancer Inst 87 (1995) 427-436
39. Ghaderi M., Wallin K.L., Wiklund F., Zake L.N., Hallmans G., Lenner P., et al. Risk of invasive cervical cancer associated with polymorphic HLA DR/DQ haplotypes. Int J Cancer 100 (2002) 698-701
40. Gregoire L., Lawrence W.D., Kukuruga D., Eisenbrey A.B., and Lancaster W.D. Association between HLA-DQB1 alleles and risk of cervical cancer in African-American women. Int J Cancer 57 (1994) 504-507
41. Wank R., Meulen J., Luande J., Eberhardt H., and Pawlita M. Cervical intraepithelial neoplasia, cervical carcinoma, and risk for patients with HLA-DQB1*0602, *0301, *0303 alleles. Lancet 341 (1993) 1215
42. Ferrera A., Olivo A., Alaez C., Melchers W.J., and Gorodezky C. HLA DQA1 and DQB1 loci in Honduran women with cervical dysplasia and invasive cervical carcinoma and their relationship to human papillomavirus infection. Hum Biol 71 (1999) 367-379
43. Dehaghani A.S., Amirzargar A., Farjadian S., and Ghaderi A. HLA-DQBl alleles and susceptibility to cervical squamous cell carcinoma in southern Iranian patients. Pathol Oncol Res 8 (2002) 58-61
44. Matsumoto K., Yasugi T., Nakagawa S., Okubo M., Hirata R., Maeda H., et al. Human papillomavirus type 16 E6 variants and HLA class II alleles among Japanese women with cervical cancer. Int J Cancer 106 (2003) 919-922
45. Lema C., Fuessel-Haws A.L., Lewis L.R., Rady P.L., Lee P., Turbat-Herrera E.A., et al. Association between HLA-DQB1 and cervical dysplasia in Vietnamese women. Int J Gynecol Cancer 16 (2006) 1269-1277
46. Ghaderi M., Zake L.N., Wallin K., Wiklund F., Hallmans G., Lenner P., et al. Tumor necrosis factor A and MHC class I chain related gene A (MIC-A) polymorphisms in Swedish patients with cervical cancer. Hum Immunol 62 (2001) 1153-1158
47. Odunsi K., Terry G., Ho L., Bell J., Cuzick J., and Ganesan T.S. Association between HLA DQB1* 03 and cervical intra-epithelial neoplasia. Mol Med 1 (1995) 161-171
48. Dao D.D., Sierra-Torres C.H., Robazetti S.C., de Gomez M.N., König R., Lema C., et al. HLA-DQB1 and cervical cancer in Venezuelan women. Gynecol Oncol 96 (2005) 349-354
49. Montoya L., Saiz I., Rey G., Vela F., and Clerici-Larradet N. Cervical carcinoma: human papillomavirus infection and HLA-associated risk factors in the Spanish population. Eur J Immunogenet 25 (1998) 329-337
50. Madeleine M.M., Johnson L.G., Smith A.G., Hansen J.A., Nisperos B.B., Li S., et al. Comprehensive analysis of HLA-A, HLA-B, HLA-C, HLA-DRB1, and HLA-DQB1 loci and squamous cell cervical cancer risk. Cancer Res 68 (2008) 3532-3539
51. Lin P., Koutsky L.A., Critchlow C.W., Apple R.J., Hawes S.E., Hughes J.P., et al. HLA class II DR-DQ and increased risk of cervical cancer among Senegalese women. Cancer Epidemiol Biomarkers Prev 10 (2001) 1037-1045
52. Sastre-Garau X., Loste M.N., Vincent-Salomon A., Favre M., Mouret E., de la Rochefordiere A., et al. Decreased frequency of HLA-DRB1 13 alleles in Frenchwomen with HPV-positive carcinoma of the cervix. Int J Cancer 69 (1996) 159-164
53. Bhattacharya P., and Sengupta S. Predisposition to HPV16/18-related cervical cancer because of proline homozygosity at codon 72 of p53 among Indian women is influenced by HLA-B*07 and homozygosity of HLA-DQB1*03. Tissue Antigens 70 (2007) 283-293
54. Mahmud S.M., Robinson K., Richardson H., Tellier P.P., Ferenczy A.S., Roger M., et al. HLA polymorphisms and cervical human papillomavirus infection in a cohort of Montreal University students. J Infect Dis 196 (2007) 82-90
55. Maciag P.C., Schlecht N.F., Souza P.S., Rohan T.E., Franco E.L., and Villa L.L. Polymorphisms of the human leukocyte antigen DRB1 and DQB1 genes and the natural history of human papillomavirus infection. J Infect Dis 186 (2002) 164-172
56. Chan P.K., Cheung T.H., Lin C.K., Siu S.S., Yim S.F., Lo K.W., et al. Association between HLA-DRB1 polymorphism, high-risk HPV infection and cervical neoplasia in southern Chinese. J Med Virol 79 (2007) 970-976
57. Glew S.S., Duggan-Keen M., Ghosh A.K., Ivinson A., Sinnott P., Davidson J., et al. Lack of association of HLA polymorphisms with human papillomavirus-related cervical cancer. Hum Immunol 37 (1993) 157-164
58. Rani R., Sood A., and Goswami R. Molecular basis of predisposition to develop type 1 diabetes mellitus in north Indians. Tissue Antigens 64 (2004) 145-155
59. Sharma S.K., Balamurugan A., Pandey R.M., Saha P.K., and Mehra N.K. Human leukocyte antigen-DR alleles influence the clinical course of pulmonary sarcoidosis in Asian Indians. Am J Respir Cell Mol Biol 29 (2003) 225-231
60. Rajalingam R., Krausa P., Shilling H.G., Stein J.B., Balamurugan A., McGinnis M.D., et al. Distinctive KIR and HLA diversity in a panel of north Indian Hindus. Immunogenetics 53 (2002) 1009-1019